{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T04:32:53Z","timestamp":1773376373808,"version":"3.50.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["lrjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.leukres.2013.08.010","type":"journal-article","created":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T13:46:24Z","timestamp":1378043184000},"page":"1572-1575","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Characterization of bone marrow mast cells in acute myeloid leukemia with t(8;21) (q22;q22); RUNX1-RUNX1T1"],"prefix":"10.1016","volume":"37","author":[{"given":"Sheeja T.","family":"Pullarkat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinod","family":"Pullarkat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anand","family":"Lagoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Russell","family":"Brynes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence M.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria","family":"Bedell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wengang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl","family":"Gaal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis D.","family":"Weisenburger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young S.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2013.08.010_bib0005","series-title":"WHO classification of tumors of haematopoietic and lymphoid tissues","year":"2008"},{"key":"10.1016\/j.leukres.2013.08.010_bib0010","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S1040-8428(02)00003-3","article-title":"The role of a Runt domain transcription factor AML1\/RUNX1 in leukemogenesis and its clinical implications","volume":"45","author":"Asou","year":"2003","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.leukres.2013.08.010_bib0015","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nrc989","article-title":"Disruption of differentiation in human cancer. AML shows the way","volume":"3","author":"Tenen","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.leukres.2013.08.010_bib0020","doi-asserted-by":"crossref","first-page":"10398","DOI":"10.1073\/pnas.171321298","article-title":"AML-ETO expression is directly involved in the development of acute myeloid leukemia in the presence of additional mutations","volume":"98","author":"Yuan","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.leukres.2013.08.010_bib0025","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1182\/blood.V96.6.2108","article-title":"Analysis of the role of AML-ETO in leukemogenesis using an inducible transgenic mouse model","volume":"96","author":"Rhoades","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2013.08.010_bib0030","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.4161\/cc.4.12.2256","article-title":"AML1-ETO needs a partner","volume":"4","author":"Kuchenbauer","year":"2005","journal-title":"Cell Cycle"},{"key":"10.1016\/j.leukres.2013.08.010_bib0035","doi-asserted-by":"crossref","first-page":"9506","DOI":"10.1073\/pnas.1531730100","article-title":"An activated receptor tyrosine kinase. TEL\/PDGF cooperates with AML1\/ETO to induce acute myeloid leukemia in mice","volume":"100","author":"Grisolano","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.leukres.2013.08.010_bib0040","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1073\/pnas.0408831102","article-title":"AML1-ETO and c-KIT mutation\/overexpression in t(8;21) leukemia: implication in stepwise leukemogenesis and response to Gleevec","volume":"102","author":"Wang","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.leukres.2013.08.010_bib0045","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1097\/00000478-199809000-00013","article-title":"Diagnostic value of immunostaining for tryptase in patients with mastocytosis","volume":"22","author":"Horny","year":"1998","journal-title":"Am J Sur Pathol"},{"key":"10.1016\/j.leukres.2013.08.010_bib0050","doi-asserted-by":"crossref","first-page":"3904","DOI":"10.1200\/JCO.2006.06.9500","article-title":"Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv (16) and t(8;21): a cancer and leukemia group B study","volume":"24","author":"Paschka","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.leukres.2013.08.010_bib0055","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.leukres.2006.03.006","article-title":"Neoplastic mast cells in systemic mastocytosis associated with t(8;21) acute myeloid leukemia are derived from the leukemic clone","volume":"31","author":"Pullarkat","year":"2007","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2013.08.010_bib0060","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/j.exphem.2007.08.016","article-title":"The origin of neoplastic mast cells in systemic mastocytosis with AML1\/ETO positive acute myeloid leukemia","volume":"35","author":"Nagai","year":"2007","journal-title":"Exp Hematol"},{"issue":"11","key":"10.1016\/j.leukres.2013.08.010_bib0065","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.leukres.2012.07.001","article-title":"Involvement of a common progenitor cell in core binding factor acute myeloid leukemia associated with mastocytosis","volume":"36","author":"Cornet","year":"2012","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2013.08.010_bib0070","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/ajh.10322","article-title":"Systemic mastocytosis with associated clonal hematological non-mast cell lineage disease: analysis of clinicopathologic features and activating c-kit mutations","volume":"73","author":"Pullarkat","year":"2003","journal-title":"Am J Hematol"},{"key":"10.1016\/j.leukres.2013.08.010_bib0075","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.1182\/blood-2005-09-3640","article-title":"Prognostic impact of c-KIT mutations in core binding factor leukemias: an Italian retrospective study","volume":"107","author":"Cairoli","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2013.08.010_bib0080","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1182\/blood-2005-04-1466","article-title":"KIT-D816 mutation in AML1-ETO positive AML are associated with impaired event-free and overall survival","volume":"107","author":"Schnittger","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2013.08.010_bib0085","doi-asserted-by":"crossref","first-page":"5705","DOI":"10.1200\/JCO.2005.15.610","article-title":"Prognostic factors and outcome of core binding factor acute myeloid leukemia patients with t(8;21) differ from those of patients with inv(16): a cancer and leukemia group B study","volume":"23","author":"Marcucci","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.leukres.2013.08.010_bib0090","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/ajh.2830380319","article-title":"Concurrent acute myeloid leukemia and systemic mastocytosis","volume":"28","author":"Wong","year":"1991","journal-title":"Am J Hematol"},{"key":"10.1016\/j.leukres.2013.08.010_bib0095","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jaci.2004.02.042","article-title":"Systemic mastocytosis associated with acute myeloid leukemia: case report and implications for disease pathogenesis","volume":"114","author":"Escribano","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.leukres.2013.08.010_bib0100","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.molonc.2010.04.008","article-title":"High frequency of concomitant mastocytosis in patients with acute myeloid leukemia exhibiting the transforming KIT mutation D816V","volume":"4","author":"Fritsche-Polanz","year":"2010","journal-title":"Mol Oncol"},{"key":"10.1016\/j.leukres.2013.08.010_bib0105","doi-asserted-by":"crossref","first-page":"473","DOI":"10.3109\/10428190009058500","article-title":"Clinical and biologic diversity of leukemias occurring in patients with mastocytosis","volume":"37","author":"Sperr","year":"2000","journal-title":"Leuk Lymph"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212613002920?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212613002920?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,3]],"date-time":"2020-08-03T00:37:23Z","timestamp":1596415043000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212613002920"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":21,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0145212613002920"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2013.08.010","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of bone marrow mast cells in acute myeloid leukemia with t(8;21) (q22;q22); RUNX1-RUNX1T1","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2013.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}